1. Home
  2. MYSZ vs MBIO Comparison

MYSZ vs MBIO Comparison

Compare MYSZ & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo My Size Inc.

MYSZ

My Size Inc.

HOLD

Current Price

$1.75

Market Cap

2.2M

Sector

Technology

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.54

Market Cap

4.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYSZ
MBIO
Founded
1999
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
4.1M
IPO Year
2017
2023

Fundamental Metrics

Financial Performance
Metric
MYSZ
MBIO
Price
$1.75
$0.54
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
667.2K
20.1K
Earning Date
04-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
57.40
98.99
EPS
N/A
N/A
Revenue
$142,000.00
N/A
Revenue This Year
$41.64
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
125.40
N/A
52 Week Low
$0.33
$0.47
52 Week High
$4.28
$1.84

Technical Indicators

Market Signals
Indicator
MYSZ
MBIO
Relative Strength Index (RSI) 47.06 40.08
Support Level $0.50 N/A
Resistance Level $4.28 $0.56
Average True Range (ATR) 0.25 0.03
MACD -0.11 -0.00
Stochastic Oscillator 11.12 50.52

Price Performance

Historical Comparison
MYSZ
MBIO

About MYSZ My Size Inc.

My Size Inc is a fashion technology company operating an integrated portfolio of businesses designed to address the pressing challenges facing fashion brands and retailers today - size and fit accuracy, excess inventory management, circular economy solutions, and international market distribution. The company, through its subsidaries provide end-to-end support across the fashion value chain; delivers AI-driven size and fit solutions for fashion e-commerce companies. The firm has the following four segments: (i) Fashion e-commerce platform, (ii) SaaS solutions, (iii) resale platform for apparel, and (iv) wholesaling of footwear. The company generates the majority of its revenue from the fashion e-commerce platform segment.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: